HUTCHMED China Ltd (HCM) - Total Liabilities

Latest as of June 2025: GBX534.02 Million GBX

Based on the latest financial reports, HUTCHMED China Ltd (HCM) has total liabilities worth GBX534.02 Million GBX as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

HUTCHMED China Ltd - Total Liabilities Trend (2005–2024)

This chart illustrates how HUTCHMED China Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

HUTCHMED China Ltd Competitors by Total Liabilities

The table below lists competitors of HUTCHMED China Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Four Seasons Education Cayman NYSE:FEDU	USA	$228.88 Million
Alumexx N.V. AS:ALX	Netherlands	€30.87 Million
Ttbio Corp. TWO:6493	Taiwan	NT$354.31 Million
ECM Libra Financial Group Bhd KLSE:2143	Malaysia	RM78.99 Million
Global Uranium and Enrichment Ltd AU:GUE	Australia	AU$11.73 Million
PJX Resources Inc V:PJX	Canada	CA$275.29K
CVD Equipment Corporation NASDAQ:CVV	USA	$4.00 Million
431190 KQ:431190	Korea	₩10.07 Billion

Liability Composition Analysis (2005–2024)

This chart breaks down HUTCHMED China Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HUTCHMED China Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HUTCHMED China Ltd (2005–2024)

The table below shows the annual total liabilities of HUTCHMED China Ltd from 2005 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX502.34 Million	-6.35%
2023-12-31	GBX536.39 Million	+36.63%
2022-12-31	GBX392.57 Million	+17.84%
2021-12-31	GBX333.15 Million	+62.38%
2020-12-31	GBX205.17 Million	+34.79%
2019-12-31	GBX152.22 Million	+26.99%
2018-12-31	GBX119.86 Million	+6.11%
2017-12-31	GBX112.97 Million	-18.36%
2016-12-31	GBX138.38 Million	+8.55%
2015-12-31	GBX127.48 Million	+28.69%
2014-12-31	GBX99.06 Million	+22.55%
2013-12-31	GBX80.83 Million	-35.76%
2012-12-31	GBX125.82 Million	+7.13%
2011-12-31	GBX117.44 Million	+28.89%
2010-12-31	GBX91.12 Million	+73.71%
2009-12-31	GBX52.45 Million	+56.43%
2008-12-31	GBX33.53 Million	+11.93%
2007-12-31	GBX29.96 Million	+29.89%
2006-12-31	GBX23.06 Million	-74.63%
2005-12-31	GBX90.89 Million	--

About HUTCHMED China Ltd

LSE:HCM UK Drug Manufacturers - Specialty & Generic

Market Cap

$23.00 Million

GBX189.05 Billion GBX

Market Cap Rank

#27531 Global

#477 in UK

Share Price

GBX220.00

Change (1 day)

+0.00%

52-Week Range

GBX193.00 - GBX286.00

All Time High

GBX624.00